Cyclic compounds useful as inhibitors of platelet glycoprotein I

Details Cyclic compounds useful as inhibitors of platelet glycoprotein I Cyclic compounds useful as inhibitors of platelet glycoprotein I

1995-06-05

1997-06-03

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 9, 514 2, 530317, A61K 3812

Patent

active

056354770

ABSTRACT:
This invention relates to novel cyclic compounds containing carbocyclic ring systems useful as antagonists of the platelet glycoprotein IIb/IIIa complex, to pharmaceutical compositions containing such cyclic compounds, with or without other therapeutic agents, and to methods of using these compounds, with or without other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of other thromboembolic disorders. This invention also relates to methods of using the cyclic compounds of the invention in combination with anti-coagulants such as warfarin or heparin, or additional anti-platelet agents such as aspirin, piroxicam or ticlopidine, or thrombin inhibitors such as boropeptides, hirudin or argatroban, or thrombolytic agents such as tissue plasminogen activator, anistreplase, urokinase or streptokinase, or combinations thereof, for the treatment of thromboembolic disorders. A representative compound of the invention is cyclo(D-Val-(.sup..alpha. N-methyl Arg)-Gly-Asp-(3-aminomethylbenzoic acid).

REFERENCES:
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4952562 (1990-08-01), Klein et al.
patent: 5041380 (1991-08-01), Ruoslahti et al.
patent: 5041430 (1991-08-01), Addicks et al.
Cadroy et al., J. Clin. Invest. vol. 84, 939-944 (1989).
Alig et al., J. Med. Chem. vol. 35, 4393-4407 (1992).
Editors: Smith et al. "Peptides--Proceedings of 12th American Peptide Symposium, Jun. 1991, Cambridge, USA" 1992, Escom, Leiden, Holland & Burner et al. Small cyclic RGD containing peptides as potent inhibitors of platelet aggregation, pp. 755-756.
Ibid, Nutt et al. "Development of Novel, highly selective fibrinogen receptor antagonists as potentially useful antithrombic agents"; pp. 914-916.
Editors: Giralt et al. "Peptides 1990--Proceedings of the 21st European Peptide Symposium, Sep. 1990, Platja D'Aro, Spain" 1991, Escom, Leiden, Holland & Nutt et al. Structure-and conformation-activity studies leading to potent fibrinogen receptor antagonists containing Arg-Gly-Asp; pp. 784-786.
Biochemical and Biophysical Research Communications, vol. 177(1), May 1991, pp. 74-82; Kumagai et al. pp. 80-81.
Fuster et al., The New England Journal of Medicine, vol. 320, No. 6, pp. 392-394 (1989).
Lewis et al., The New England Journal of Medicine, vol. 309, No. 7, pp. 396-403 (1983).
Cairns et al., The New England Journal of Medicine, vol. 313, No. 22, pp. 1369-1375 (1985).
Fuster et al., Perspective, vol. 77, No. 6, 1213-1220 (1988).
Schafer et al., J. Clin. Invest., vol. 75, pp. 456-461 (1985).
Schafer et al., J. Clin. Invest., vol. 78, pp. 73-79 (1986).
Fitzgerald et al., Circulation, vol. 77, No. 1, pp. 142-150 (1988).
Yasuda et al., J. Clin. Invest., vol. 81, pp. 1284-1291 (1988).
Gold et al., Circulation, vol. 77(3), pp. 670-677 (1988).
Shebuski, J. Biological Chem., vol. 264(36), pp. 21550-21556 (1989).
Stamler et al., Circulation Research, vol. 65, pp. 796-804 (1989).
Lam et al., J. Pharmacology and Experimental Therapeutics, vol. 259(3), pp. 1371-1378 (1991).
Collen et al., Annu. Rev. Med., vol. 39, pp. 405-423 (1988).
Simons et al., Annu. Rev. Med., vol. 40, pp. 181-200 (1989).
Davidson et al., Circ. vol. 85, pp. 124 & 492 (1991).
Gold et al., Circ., vol. 84, pp. 124 & 496 (1991).
Haskel et al., Thrombosis Research, vol. 56, pp. 687-695 (1989).
Phillips et al., Cell, vol. 65, pp. 359-362 (1991).

Affiliated with

Also associated with

Rating

Cyclic compounds useful as inhibitors of platelet glycoprotein I does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic compounds useful as inhibitors of platelet glycoprotein I, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic compounds useful as inhibitors of platelet glycoprotein I will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-391659